These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36438246)

  • 21. Citizen science: Exploring its application as a tool for prodromic surveillance of vector-borne disease.
    Hines D; Sibbald SL
    Can Commun Dis Rep; 2015 Mar; 41(3):63-67. PubMed ID: 29769934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital and technological innovation in vector-borne disease surveillance to predict, detect, and control climate-driven outbreaks.
    Pley C; Evans M; Lowe R; Montgomery H; Yacoub S
    Lancet Planet Health; 2021 Oct; 5(10):e739-e745. PubMed ID: 34627478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public perceptions of Lyme disease and climate change in southern Manitoba, Canada: making a case for strategic decoupling of climate and health messages.
    Cameron L; Rocque R; Penner K; Mauro I
    BMC Public Health; 2021 Mar; 21(1):617. PubMed ID: 33781235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consolidating tactical planning and implementation frameworks for integrated vector management in Uganda.
    Okia M; Okui P; Lugemwa M; Govere JM; Katamba V; Rwakimari JB; Mpeka B; Chanda E
    Malar J; 2016 Apr; 15():214. PubMed ID: 27074809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vector-borne disease surveillance in livestock populations: A critical review of literature recommendations and implemented surveillance (BTV-8) in five European countries.
    Dórea FC; Elbers AR; Hendrikx P; Enoe C; Kirkeby C; Hoinville L; Lindberg A
    Prev Vet Med; 2016 Mar; 125():1-9. PubMed ID: 26783200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Easier surveillance of climate-related health vulnerabilities through a Web-based spatial OLAP application.
    Bernier E; Gosselin P; Badard T; Bédard Y
    Int J Health Geogr; 2009 Apr; 8():18. PubMed ID: 19344512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decision tool for climate disasters and infectious disease at sub-national level in India: Ensuring a paradigm shift in health planning from prevalence to vulnerability.
    Dogra N; Kakde V; Taneja P
    Acta Trop; 2019 Mar; 191():60-68. PubMed ID: 30553895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combatting the Increasing Threat of Vector-Borne Disease in the United States with a National Vector-Borne Disease Prevention and Control System.
    Petersen LR; Beard CB; Visser SN
    Am J Trop Med Hyg; 2019 Feb; 100(2):242-245. PubMed ID: 30499427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Climate change and vector-borne diseases in Argentina].
    Gorla DE
    Medicina (B Aires); 2021; 81(3):432-437. PubMed ID: 34137705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vector-Borne diseases in Egypt: Present status and accelerating toward elimination.
    Eassa SM; Abd El-Wahab EW
    J Vector Borne Dis; 2022; 59(2):127-138. PubMed ID: 36124478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards an integrated approach in surveillance of vector-borne diseases in Europe.
    Braks M; van der Giessen J; Kretzschmar M; van Pelt W; Scholte EJ; Reusken C; Zeller H; van Bortel W; Sprong H
    Parasit Vectors; 2011 Oct; 4():192. PubMed ID: 21967706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information.
    Ogden NH; Koffi JK; Pelcat Y; Lindsay LR
    Can Commun Dis Rep; 2014 Mar; 40(5):74-82. PubMed ID: 29769885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change.
    Ogden NH; St-Onge L; Barker IK; Brazeau S; Bigras-Poulin M; Charron DF; Francis CM; Heagy A; Lindsay LR; Maarouf A; Michel P; Milord F; O'Callaghan CJ; Trudel L; Thompson RA
    Int J Health Geogr; 2008 May; 7():24. PubMed ID: 18498647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will integrated surveillance systems for vectors and vector-borne diseases be the future of controlling vector-borne diseases? A practical example from China.
    Wu Y; Ling F; Hou J; Guo S; Wang J; Gong Z
    Epidemiol Infect; 2016 Jul; 144(9):1895-903. PubMed ID: 26899818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A framework for evaluating the effects of observational type and quality on vector-borne disease forecast.
    Yamana TK; Shaman J
    Epidemics; 2020 Mar; 30():100359. PubMed ID: 31439454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.